Soluble HLA‐G levels were significantly higher in gynecological cancers compared with the controls (SMD = 1.434, 95% CI = 0.442–2.426, p = 0.005) (Figure 6A). This evidence concerns the gene HLA-G and female reproductive organ cancer.